Fulltext

The International Patent System and Biomedical Research: Reconciling Aspiration, Policy and Practice

Taubman, Antony

In: The AAPS Journal, 2008, vol. 10, no. 4, p. 526-536

Aggiungi alla tua lista
    Titre
    • The International Patent System and Biomedical Research: Reconciling Aspiration, Policy and Practice
    Auteur
    • Taubman, Antony. Global IP Issues Division, WIPO, Geneva, Switzerland
    Type de document
    • Postprint
    Langue
    • Inglese
    Publié dans
    • The AAPS Journal, 2008, vol. 10, no. 4, p. 526-536. Springer US; http://www.springer-ny.com
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:316736
    Summary
    This article reviews how the international environment shapes international patent law and practice with bearing on biomedical innovation. The cluster of issues is encapsulated in two core paradoxes. The first concerns how public goods, such as new pharmaceuticals, may be produced through the deliberate creation of private rights that exclude material from the public domain. The second paradox concerns how "technological neutrality” and overall policy balance in the application of general patent law principles requires technology-specific interventions by regulators. The article illustrates how centrifugal and centripetal trends influence diverse national approaches to applying patentability criteria for pharmaceutical products